CR HOLDINGS(01911),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01911 CR HOLDINGS

Trading 08-06 13:05:33

3.010

-0.070

-2.27%

High3.060	Low2.995	Vol57.90K
Open3.060	D1 Closing3.080	Amplitude2.11%
Mkt Cap1.72B	Tradable Cap1.72B	Total Shares573.00M
T/O174.55K	T/O Rate0.01%	Tradable Shares573.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01911","market":"HK","secType":"STK","nameCN":"CR HOLDINGS","latestPrice":3.01,"timestamp":1785985624919,"preClose":3.08,"halted":0,"volume":57900,"delay":0,"changeRate":-0.022727272727272818,"floatShares":573000000,"shares":573000000,"eps":0.2207878925736517,"marketStatus":"Trading","change":-0.07,"latestTime":"08-06 13:05:33","open":3.06,"high":3.06,"low":2.995,"amount":174553,"amplitude":0.021104,"askPrice":3.015,"askSize":2200,"bidPrice":3.01,"bidSize":3300,"shortable":0,"etf":0,"ttmEps":0.22776014181281964,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1786003800000},"marketStatusCode":2,"adr":0,"listingDate":1537977600000,"exchange":"SEHK","adjPreClose":3.08,"openAndCloseTimeList":[[1785979800000,1785988800000],[1785992400000,1786003200000]],"volumeRatio":0.301024,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01911","defaultTab":"news","newsList":[{"id":"2657606599","title":"Innovent Biologics Jumps Most in 3 Weeks on Robust Product Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2657606599","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657606599?lang=en_us&edition=fundamental","pubTime":"2026-08-05 09:52","pubTimestamp":1785894772,"startTime":"0","endTime":"0","summary":"BUZZ-Innovent Biologics jumps most in 3 weeks on robust product revenue growth** Shares of Innovent Biologics Inc1801.HKjump 6.3% to HK$92.2, on track for the biggest one-day pct gain since July 15** Stock touches the highest level since July 24 in the second session of gain** The innovative medicine developer and producer says itsfirst half 2026 product revenueexceeds 8.2 bln yuan , up over 55% y/y, of which total revenue for the second quarter is up 60% y/y to over 4.3 bln yuan** YTD, stock up 18%, Hang Seng Biotech Index.HSBIOup 0.6%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N44201W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828557.USD","LU2097828631.EUR","LU0502904849.HKD","BK1583","LU0455707207.USD","BK1147","01911","01801","LU2097828714.EUR","LU2097828805.USD","LU2488822045.USD","BK1161","LU2242644610.SGD","BK1589","LU1969619763.USD","LU2328871848.SGD","HK0000165453.HKD","LU2097828474.EUR","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653122295","title":"China Renaissance Deploys $12 Million in Three-Month Fiduciary Time Deposit","url":"https://stock-news.laohu8.com/highlight/detail?id=2653122295","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653122295?lang=en_us&edition=fundamental","pubTime":"2026-07-21 15:42","pubTimestamp":1784619724,"startTime":"0","endTime":"0","summary":"China Renaissance  placed a $12 million three-month fiduciary time deposit through LGT Bank, with the funds deposited at CTBC Bank, according to a Monday Hong Kong bourse filing.The deposit carries an annual interest rate of 4.08% and is scheduled to mature on or about Oct. 22. The investment is part of the group's treasury management strategy to enhance returns on its working capital.Shares of the company fell 1% in recent trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01911","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178279999","title":"CR HOLDINGS Allocates $12 Million to Trust Deposits","url":"https://stock-news.laohu8.com/highlight/detail?id=1178279999","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178279999?lang=en_us&edition=fundamental","pubTime":"2026-07-20 22:06","pubTimestamp":1784556381,"startTime":"0","endTime":"0","summary":"CR HOLDINGS (HKEX: 01911) has announced that on July 20, 2026, the group, through its wholly-owned subsidiary acting as the subscriber, has subscribed for trust deposits with a total principal amount...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01911","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168470345","title":"CR HOLDINGS places USD 12.00 million fiduciary time deposit with LGT Bank at 4.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168470345","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168470345?lang=en_us&edition=fundamental","pubTime":"2026-07-20 22:02","pubTimestamp":1784556143,"startTime":"0","endTime":"0","summary":"CR HOLDINGS (China Renaissance Holdings Limited) disclosed that on 20 July 2026 its wholly-owned subsidiary, China Renaissance Capital Limited, subscribed to a USD-denominated fiduciary time deposit...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01911"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652219977","title":"China Renaissance - Places US$12 Mln Fiduciary Deposit Through Lgt on July 20, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2652219977","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652219977?lang=en_us&edition=fundamental","pubTime":"2026-07-20 21:56","pubTimestamp":1784555786,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nFWN43M0GD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01911","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190083303","title":"CR HOLDINGS Appoints Liu Taojiang to Lead Hong Kong Stock Investment Banking","url":"https://stock-news.laohu8.com/highlight/detail?id=1190083303","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190083303?lang=en_us&edition=fundamental","pubTime":"2026-07-20 15:10","pubTimestamp":1784531439,"startTime":"0","endTime":"0","summary":"On July 20, CR HOLDINGS (ASX: 01911) announced that Mr. Liu Taojiang has officially joined the company as Managing Director and Head of Hong Kong Stock Investment Banking.Mr. Liu will be fully...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01911","BK1147","VXUS","BK4585","DFNL","FYLG","RSPF","BK4588","KCAI","IYG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651714291","title":"Innovent Biologics Licenses Anti-cd40l Antibody Ibi355 to Spero in Deal Worth About USD 1.1 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2651714291","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651714291?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:01","pubTimestamp":1784023267,"startTime":"0","endTime":"0","summary":"Innovent Biologics licenses anti-CD40L antibody IBI355 to Spero in deal worth about USD 1.1 billionInnovent Biologics signed an exclusive license with Spero Therapeutics for IBI355 (SP001), a Phase 2-","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL8vw8t6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","LU2097828474.EUR","01911","BK1161","LU2488822045.USD","LU2097828714.EUR","LU2097828557.USD","HK0000165453.HKD","LU2097828631.EUR","LU0502904849.HKD","LU2328871848.SGD","01801","BK1583","LU0455707207.USD","LU1969619763.USD","BK1147","LU2097828805.USD","LU2242644610.SGD","KURE","BK4139","SPRO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649352199","title":"Innovent Biologics Files HKEX Next-day Return, Share Capital Rises by 1,882,334 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2649352199","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649352199?lang=en_us&edition=fundamental","pubTime":"2026-07-07 22:41","pubTimestamp":1783435296,"startTime":"0","endTime":"0","summary":"Innovent Biologics files HKEX next-day return, share capital rises by 1,882,334 sharesInnovent Biologics filed a next day disclosure return reporting 1,882,334 new ordinary shares issued on July 3, 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL8VhNVk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","LU1969619763.USD","LU2097828631.EUR","BK1147","LU0502904849.HKD","01911","BK1583","BK1161","LU2097828714.EUR","LU2242644610.SGD","LU2328871848.SGD","KURE","LU0455707207.USD","LU2488822045.USD","HK0000165453.HKD","LU2097828474.EUR","01801","LU2097828805.USD","LU2097828557.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649623327","title":"China Renaissance Says CRCL Enters Investment Account Management Agreement with CSCI Am","url":"https://stock-news.laohu8.com/highlight/detail?id=2649623327","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649623327?lang=en_us&edition=fundamental","pubTime":"2026-07-06 18:18","pubTimestamp":1783333103,"startTime":"0","endTime":"0","summary":"BRIEF-China Renaissance Says CRCL Enters Investment Account Management Agreement With CSCI AMJuly 6 -China Renaissance Holdings Ltd1911.HK:CRCL ENTERS INVESTMENT ACCOUNT MANAGEMENT AGREEMENT WITH CSCI AM ON JULY 6, 2026CRCL TO APPOINT CSCI AM TO MANAGE PORTFOLIO WITH INITIAL INVESTMENT UP TO $20 MILLIONFurther company coverage:1911.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nFWN4350GH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01911","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153728401","title":"CR Holdings commits US$30.00 million to CITIC Securities bond-linked wealth product","url":"https://stock-news.laohu8.com/highlight/detail?id=1153728401","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153728401?lang=en_us&edition=fundamental","pubTime":"2026-07-06 17:42","pubTimestamp":1783330972,"startTime":"0","endTime":"0","summary":"China Renaissance Holdings Limited (CR Holdings) disclosed that its wholly-owned subsidiary, China Renaissance Capital Limited, subscribed on 6 July 2026 for a US$30.00 million USD Managed Portfolio...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01911"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649364043","title":"China Renaissance Unit Hires CSCI am to Manage USD 20 Million Investment Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2649364043","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649364043?lang=en_us&edition=fundamental","pubTime":"2026-07-06 17:36","pubTimestamp":1783330596,"startTime":"0","endTime":"0","summary":"China Renaissance unit hires CSCI AM to manage USD 20 million investment portfolioChina Renaissance’s unit signed a discretionary investment account management agreement with CSCI AM on July 6, 2026.I","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nNDL9TQz53:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01911","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649640136","title":"China Renaissance - Crcl to Appoint Csci am to Manage Portfolio with Initial Investment up to $20 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2649640136","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649640136?lang=en_us&edition=fundamental","pubTime":"2026-07-06 17:35","pubTimestamp":1783330558,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nFWN4350GH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01911","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649640156","title":"China Renaissance - Subscribes for Wealth Management Product at Aggregate Subscription Amount of US$30 Mln on July 6, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2649640156","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649640156?lang=en_us&edition=fundamental","pubTime":"2026-07-06 17:32","pubTimestamp":1783330323,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nFWN4380GR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1147","01911"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191688831","title":"CR HOLDINGS Monthly Return: Share Capital Stable at 573.35 million Shares; Public Float Meets 25% Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=1191688831","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191688831?lang=en_us&edition=fundamental","pubTime":"2026-07-02 17:45","pubTimestamp":1782985542,"startTime":"0","endTime":"0","summary":"China Renaissance Holdings Limited (CR HOLDINGS) submitted its Monthly Return for the period ended 30 June 2026. Key points are as follows: • Share capital unchanged: authorised capital remained at...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01911"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647581233","title":"Innovent, Lilly Team up to Commercialize Verzenios in Mainland China","url":"https://stock-news.laohu8.com/highlight/detail?id=2647581233","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647581233?lang=en_us&edition=fundamental","pubTime":"2026-06-30 12:00","pubTimestamp":1782792021,"startTime":"0","endTime":"0","summary":"Innovent, Lilly team up to commercialize Verzenios in mainland ChinaInnovent entered a distribution and promotion deal with Eli Lilly for Verzenios (abemaciclib) in mainland China.Innovent takes impor","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDLbMC9L9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","BK1583","BK1589","HK0000165453.HKD","LU2097828557.USD","LU1969619763.USD","LU2097828631.EUR","LU2328871848.SGD","BK1161","LU0502904849.HKD","01911","LU2097828474.EUR","LU2097828714.EUR","BK1147","LU2242644610.SGD","LU2488822045.USD","LU0455707207.USD","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647810435","title":"Futu Stock Faces Fresh Regulatory Questions After Guo Wengui Verdict","url":"https://stock-news.laohu8.com/highlight/detail?id=2647810435","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647810435?lang=en_us&edition=fundamental","pubTime":"2026-06-30 11:26","pubTimestamp":1782789993,"startTime":"0","endTime":"0","summary":"Cross-border Chinese wealth management and brokerage stocks are suddenly under a harsh spotlight after the sentencing of tycoon Guo Wengui in the US for a billion-dollar fraud scheme. For you as an investor, this kind of shock can reshape how regulators, clients, and counterparties view risk around Chinese capital flows and financial platforms. This article explains how that shift may affect a handful of Chinese Wealth Management and Brokerage Stocks With Regulatory Exposure, and walks...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/7132000-choice2-main-header/1585186691278","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7132000-choice2-main-header/1585186691278"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/diversified-financials/hkg-1911/china-renaissance-holdings-shares/news/futu-stock-faces-fresh-regulatory-questions-after-guo-wengui","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/diversified-financials/hkg-1911/china-renaissance-holdings-shares/news/futu-stock-faces-fresh-regulatory-questions-after-guo-wengui","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4531","LU1981816686.USD","BK4127","FUTU","BK4509","BK4585","BK4566","BK4503","BK4526","BK4135","LU0348766576.USD","NOAH","LU0348767384.USD","BK4588","FUTG","LU0072462343.USD","BK1147","LU1048588211.SGD","01911","SG9999002463.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646841159","title":"Innovent Biologics Files Directors List with Hong Kong Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2646841159","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646841159?lang=en_us&edition=fundamental","pubTime":"2026-06-25 06:17","pubTimestamp":1782339422,"startTime":"0","endTime":"0","summary":"Innovent Biologics files directors list with Hong Kong Stock ExchangeInnovent filed an updated list of directors with the Hong Kong Stock Exchange dated June 25, 2026.Board leadership unchanged, with ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nNDLc2VtBS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828805.USD","BK1161","HK0000165453.HKD","LU2097828557.USD","LU2097828474.EUR","LU1969619763.USD","01911","BK1147","LU2242644610.SGD","BK1589","LU2488822045.USD","LU2097828714.EUR","LU2097828631.EUR","LU0502904849.HKD","01801","LU0455707207.USD","LU2328871848.SGD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103820116","title":"CR Holdings: All AGM Resolutions Secure Strong Shareholder Backing, New Articles Adopted","url":"https://stock-news.laohu8.com/highlight/detail?id=1103820116","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103820116?lang=en_us&edition=fundamental","pubTime":"2026-06-23 18:05","pubTimestamp":1782209115,"startTime":"0","endTime":"0","summary":"China Renaissance Holdings Limited (CR Holdings, 01911) reported that every item on the agenda of its 23 June 2026 annual general meeting (AGM) was approved by poll, underscoring broad shareholder...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01911"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645887871","title":"China Renaissance shareholders pass bylaw amendments with 92.85% support","url":"https://stock-news.laohu8.com/highlight/detail?id=2645887871","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645887871?lang=en_us&edition=fundamental","pubTime":"2026-06-23 17:52","pubTimestamp":1782208325,"startTime":"0","endTime":"0","summary":"China Renaissance shareholders backed amendments to the company’s bylaws at its June 23, 2026 annual meeting.The special resolution passed with 92.85% voting in favor, 7.15% against.The vote adopted a sixth amended and restated memorandum and articles of association, replacing the existing version.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Renaissance Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 23, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nNDL6rMChV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01911","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645250011","title":"Innovent doses first patient in Phase 3 China trial of IBI3003 tri-specific antibody for multiple myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2645250011","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645250011?lang=en_us&edition=fundamental","pubTime":"2026-06-22 08:00","pubTimestamp":1782086418,"startTime":"0","endTime":"0","summary":"Innovent dosed the first patient in a China Phase 3 trial of IBI3003, a tri-specific antibody for relapsed or refractory multiple myeloma.The study will compare IBI3003 with standard combination regimens, with progression-free survival as the primary endpoint.Early clinical results were already presented in December 2025, showing encouraging responses with manageable safety in heavily pretreated patients.Further dose-optimization results are expected at future medical meetings, supporting the program’s registrational strategy in China.The drug also holds FDA Fast Track status for later-line patients, with a separate US Phase 1/2 study ongoing.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL82LZ0z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01801","LU2328871848.SGD","LU2097828474.EUR","01911","BK1583","BK1147","LU0455707207.USD","LU1969619763.USD","LU2097828557.USD","LU2097828714.EUR","LU2097828805.USD","LU2488822045.USD","HK0000165453.HKD","LU2242644610.SGD","BK1589","LU2097828631.EUR","LU0502904849.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinarenaissance.com","stockEarnings":[{"period":"1week","weight":-0.0314},{"period":"1month","weight":0.0548},{"period":"3month","weight":-0.1676},{"period":"6month","weight":-0.3032},{"period":"1year","weight":-0.4359},{"period":"ytd","weight":-0.2542}],"compareEarnings":[{"period":"1week","weight":0.0042},{"period":"1month","weight":0.0974},{"period":"3month","weight":-0.0267},{"period":"6month","weight":-0.0243},{"period":"1year","weight":0.0407},{"period":"ytd","weight":0.0111}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"China Renaissance Holdings Ltd is a holding company that is primarily engaged in providing investment banking and investment management services. The Company operates in four segments. Investment Banking segment provides early to late stage financial advisory and mergers and acquisitions advisory services, equity underwriting, sales, trading, brokerage, research services and structured financial services. Investment Management segment provides fund and asset management and manages its own investments in funds. China Renaissance (CR) Securities segment provides investment banking and asset management business. Others segment mainly includes wealth management business and investment and management of own funds.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.099096},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.014364},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.054298},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.054187},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.049653},{"month":6,"riseRate":0.833333,"avgChangeRate":0.099698},{"month":7,"riseRate":0.5,"avgChangeRate":0.05207},{"month":8,"riseRate":0.5,"avgChangeRate":0.08284},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.131486},{"month":10,"riseRate":0,"avgChangeRate":-0.130048},{"month":11,"riseRate":0.285714,"avgChangeRate":0.027229},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.035994}],"exchange":"SEHK","name":"CR HOLDINGS","nameEN":"CR HOLDINGS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CR HOLDINGS(01911),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CR HOLDINGS(01911) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CR HOLDINGS,01911,CR HOLDINGS股票,CR HOLDINGS股票老虎,CR HOLDINGS股票老虎国际,CR HOLDINGS行情,CR HOLDINGS股票行情,CR HOLDINGS股价,CR HOLDINGS股市,CR HOLDINGS股票价格,CR HOLDINGS股票交易,CR HOLDINGS股票购买,CR HOLDINGS股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CR HOLDINGS(01911),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CR HOLDINGS(01911) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}